Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 52,873 | 21,172 | 115,855 | 15,414 | 24,045 |
| Marketable Securities | 156,516 | 205,687 | 130,730 | 127,053 | 133,183 |
| Receivables | 1,296 | 858 | 838 | 958 | 784 |
| TOTAL | $213,516 | $230,314 | $249,380 | $145,024 | $160,138 |
| Non-Current Assets | |||||
| PPE Net | 6,193 | 6,417 | 6,328 | 6,730 | 6,943 |
| Other Non-Current Assets | 1,086 | 827 | 132 | 149 | 163 |
| TOTAL | $7,279 | $7,244 | $6,460 | $6,879 | $7,106 |
| Total Assets | $220,795 | $237,558 | $255,840 | $151,903 | $167,244 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 12 | 49 | 84 |
| Accounts payable and accrued liabilities | 16,493 | 11,341 | 8,735 | 12,207 | 10,206 |
| TOTAL | $17,262 | $11,583 | $9,239 | $13,134 | $13,921 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 769 | 242 | 492 | 878 | 3,631 |
| Other Non-Current Liabilities | 2,237 | 2,219 | 2,259 | 2,227 | 2,290 |
| TOTAL | $2,237 | $2,219 | $2,259 | $2,227 | $2,290 |
| Total Liabilities | $19,499 | $13,802 | $11,498 | $15,361 | $16,212 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 33,603 | 30,070 | 30,074 | 30,077 | 24,917 |
| Common Shares | 30 | 30 | 30 | 24 | 24 |
| Retained earnings | -395,282 | -368,000 | -342,896 | -328,798 | -310,912 |
| Other shareholders' equity | -69 | 90 | 80 | 70 | -41 |
| TOTAL | $201,296 | $223,756 | $244,342 | $136,542 | $151,033 |
| Total Liabilities And Equity | $220,795 | $237,558 | $255,840 | $151,903 | $167,244 |